首站-论文投稿智能助手
典型文献
Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming
文献摘要:
Helichrysetin(HEL),a chalcone isolated from Alpinia katsumadai Hayata,has an antitumor activity in human lung and cervical cancers.However,the inhibitory effect and underlying mechanism of HEL in gastric cancer have not been elucidated.Here,HEL significantly inhibited the growth of gastric cancer MGC803 cells in vitro and in vivo.HEL decreased expression and transcriptional regulatory activity of c-Myc and mRNA expression of c-Myc target genes.HEL enhanced mitochondrial oxidative phosphorylation(OXPHOS)and reduced glycolysis as evidenced by increased mitochondrial adenosine triphosphate(ATP)production and excessive reactive oxygen species(ROS)accumulation,and decreased the pPDHA1/PDHA1 ratio and Glyco-ATP production.Pyruvate enhanced OXPHOS after HEL treatment.c-Myc overexpression abolished HEL-induced inhibition of cell viability,glycolysis,and protein expression of PDHK1 and LDHA.PDHK1 overexpression also counteracted inhibitory effect of HEL on cell viability.Conversely,c-Myc siRNA decreased cell viability,glycolysis,and PDHK1 expression.NAC rescued the decrease in viability of HEL-treated cells.Additionally,HEL inhibited the overactivated mTOR/p70S6K pathway in vitro and in vivo.HEL-induced cell viability inhibition was counteracted by an mTOR agonist.mTOR inhibitor also decreased cell viability.Similar results were obtained in SGC7901 cells.HEL repressed lactate production and efflux in MGC803 cells.These results revealed that HEL inhibits gastric cancer growth by targeting mTOR/p70S6K/c-Myc/PDHK1-mediated energy metabolism reprogramming in cancer cells.Therefore,HEL may be a potential agent for gastric cancer treatment by modulating cancer energy metabolism reprogramming.
文献关键词:
作者姓名:
Ping Wang;Jin-mei Jin;Xiao-hui Liang;Ming-zhu Yu;Chun Yang;Fei Huang;Hui Wu;Bei-bei Zhang;Xiao-yan Fei;Zheng-tao Wang;Ren Xu;Hai-lian Shi;Xiao-jun Wu
作者机构:
Shanghai Key Laboratory of Compound Chinese Medicines,The Ministry of Education(MOE)Key Laboratory for Standardization of Chinese Medicines,The SATCM Key Laboratory for New Resources&Quality Evaluation of Chinese Medicine,Research Center of Shanghai Traditional Chinese Medicine Standardization,Institute of Chinese Materia Medica,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Markey Cancer Center,Department of Pharmacology and Nutritional Sciences,University of Kentucky College of Medicine,Lexington,KY,USA
引用格式:
[1]Ping Wang;Jin-mei Jin;Xiao-hui Liang;Ming-zhu Yu;Chun Yang;Fei Huang;Hui Wu;Bei-bei Zhang;Xiao-yan Fei;Zheng-tao Wang;Ren Xu;Hai-lian Shi;Xiao-jun Wu-.Helichrysetin inhibits gastric cancer growth by targeting c-Myc/PDHK1 axis-mediated energy metabolism reprogramming)[J].中国药理学报(英文版),2022(06):1581-1593
A类:
Helichrysetin,PDHK1,katsumadai,pPDHA1,overactivated
B类:
inhibits,gastric,growth,by,targeting,Myc,axis,mediated,energy,metabolism,reprogramming,HEL,chalcone,isolated,from,Alpinia,Hayata,has,antitumor,activity,human,lung,cervical,cancers,However,inhibitory,effect,underlying,mechanism,have,not,been,elucidated,Here,significantly,inhibited,MGC803,cells,vitro,vivo,decreased,transcriptional,regulatory,genes,enhanced,mitochondrial,oxidative,phosphorylation,OXPHOS,reduced,glycolysis,evidenced,increased,adenosine,triphosphate,ATP,production,excessive,reactive,oxygen,species,ROS,accumulation,ratio,Glyco,Pyruvate,after,treatment,overexpression,abolished,induced,inhibition,viability,protein,LDHA,also,counteracted,Conversely,siRNA,NAC,rescued,treated,Additionally,mTOR,p70S6K,pathway,was,agonist,Similar,results,were,obtained,SGC7901,repressed,lactate,efflux,These,revealed,that,Therefore,may,potential,agent,modulating
AB值:
0.436632
相似文献
Romidepsin (FK228) improves the survival of allogeneic skin grafts through downregulating the production of donor-specific antibody via suppressing the IRE1 α-XBP1 pathway
Yuliang GUO;Siyu SONG;Xiaoxiao DU;Li TIAN;Man ZHANG;Hongmin ZHOU;Zhonghua Klaus CHEN;Sheng CHANG-Institute of Organ Transplantation,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Key Laboratory of Organ Transplantation,Ministry of Education,NHC Key Laboratory of Organ Transplantation,Key Laboratory of Organ Transplantation,Chinese Academy of Medical Sciences,Wuhan 430030,China;Henan Key Laboratory of Digestive Organ Transplantation,Open and Key Laboratory of Hepatobiliary&Pancreatic Surgery and Digestive Organ Transplantation at Henan Universities,Zhengzhou Key Laboratory of Hepatobiliary&Pancreatic Diseases and Organ Transplantation,Department of Hepatobiliary and Pancreatic Surgery,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;Department of Cardiothoracic and Vascular Surgery,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China
Spirulina platensis aqueous extracts ameliorate colonic mucosal damage and modulate gut microbiota disorder in mice with ulcerative colitis by inhibiting inflammation and oxidative stress
Jian WANG;Liqian SU;Lun ZHANG;Jiali ZENG;Qingru CHEN;Rui DENG;Ziyan WANG;Weidong KUANG;Xiaobao JIN;Shuiqing GUI;Yinghua XU;Xuemei LU-Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances,School of Life Science and Biopharmaceutics,Guangdong Pharmaceutical University,Guangzhou 510006,China;School of Pharmacy,Guangdong Pharmaceutical University,Guangzhou 510006,China;Intensive Care Unit,Shenzhen Second People's Hospital,the First Affiliated Hospital of Shenzhen University,Shenzhen 518031,China;Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products,National Institutes for Food and Drug Control,Beijing 102629,China
Fuzheng Kang'ai decoction(扶正抗癌方)inhibits cell proliferation,migration and invasion by modulating mir-21-5p/human phosphatase and tensin homology deleted on chromosome ten in lung cancer cells
LI Jinhua;LIU Chunping;ZHAO Yueyang;WU Wanyin;SUN Pengtao;LI Longmei;YANG Xiaobing;ZHOU Yushu-Department of Ultrasound,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Ultrasound,Institute of Ultrasound in Musculoskeletal Sports Medicine,Guangdong Second Provincial General Hospital,Guangzhou 510317,China;State Key Laboratory of Dampness Syndrome of Chinese Medicine,Guangdong Provincial Hospital of Chinese Medicine,The Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Hematology,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China;Department of Oncology,Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC,Guangdong Provincial Hospital of Chinese Medicine,the Second Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510120,China
Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+T cell-mediated ferroptosis in castration-resistant prostate cancer
Xumin Zhou;Libin Zou;Hangyu Liao;Junqi Luo;Taowei Yang;Jun Wu;Wenbin Chen;Kaihui Wu;Shengren Cen;Daojun Lv;Fangpeng Shu;Yu Yang;Chun Li;Bingkun Li;Xiangming Mao-Department of Urology,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Second Department of Hepatobiliary Surgery,Zhujiang Hospital,Southern Medical University,Guangzhou 510280,China;Department of Urology,Minimally Invasive Surgery Center,the First Affiliated Hospital of Guangzhou Medical University,Guangzhou 510120,China;Department of Urology,Guangzhou Women and Children's Medical Center,Guangzhou Medical University,Guangzhou 510623,China;Department of Urology,Peking University Shenzhen Hospital,Shenzhen 518036,China;Nursing Department,Nanfang Hospital,Southern Medical University,Guangzhou 510515,China
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Abivertinib inhibits megakaryocyte differentiation and platelet biogenesis
Jiansong Huang;Xin Huang;Yang Li;Xia Li;Jinghan Wang;Fenglin Li;Xiao Yan;Huanping Wang;Yungui Wang;Xiangjie Lin;Jifang Tu;Daqiang He;Wenle Ye;Min Yang;Jie Jin-Department of Hematology,Key Laboratory of Hematologic Malignancies,Diagnosis and Treatment,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Institute of Hematology,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Obstetrics,The First Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Department of Hematology,Qingdao Municipal Hospital,Qingdao 266000,China;Department of Laboratory Medicine,Affiliated Hangzhou First People's Hospital,Zhejiang University School of Medicine,Hangzhou 310003,China;Cancer Center Zhejiang University,Hangzhou 310058,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。